Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens

Molecular Pharmaceutics

Volumn 7, Issue 6, 2010, Pages 2289-2296

  Privett, Benjamin J ^a   Deupree, Susan M ^a   Backlund, Christopher J ^a   Rao, Kavitha S ^a   Johnson, C Bryce ^a   Coneski, Peter N ^a   Schoenfisch, Mark H ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZENIUMDIOLATE MODIFIED PROLINE; NITRIC OXIDE; PROLINE; SULFADIAZINE SILVER; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BURN; CHRONIC WOUND; CONCENTRATION RESPONSE; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; NITRIC OXIDE; SILVER SULFADIAZINE;

EID: 78649980821     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100248e     Document Type: Article

References (55)

1. Russell, A. D.; Hugo, W. B. Antimicrobial activity and action of silver Prog. Med. Chem. 1994, 31, 351-371
2. Bragg, P. D.; Rainne, D. G. The effect of silver ions on the respiratory chain of Escherichia coli Can. J. Microbiol. 1974, 20, 883-889
3. + in Vibrio cholerae Antimicrob. Agents Chemother. 2002, 46, 2668-2670
4. Modak, S. M.; Fox, J. C. L. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa Biochem. Pharmacol. 1973, 22, 2391-2404
5. Feng, Q. L.; Wu, J.; Chen, G. Q.; Cui, F. Z.; Kim, T. N.; Kim, J. O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus J. Biomed. Mater. Res. 2000, 52, 662-668
6. + Biochemistry 2005, 44, 13214-13223
7. Silver, S.; Phung, L. T.; Silver, G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds J. Ind. Microbiol. Biotechnol. 2006, 33, 627-634
8. Carr, H. S.; Wlodkowski, T. J.; Rosenkranz, H. S. Silver sulfadiazine: in vitro antibacterial activity Antimicrob. Agents Chemother. 1973, 4, 585-587
9. Wlodkowski, T. J.; Rosenkranz, H. S. Antifungal activity of silver sulphadiazine Lancet 1973, ii, 739-740
10. Fang, F. C. Host/pathogen interactions: Mechanisms of nitric oxide-related antimicrobial activity J. Clin. Invest. 1997, 99, 2818-2825
11. Bogdan, C. Nitric oxide and the immune response Nat. Immunol. 2001, 2, 907-916
12. Foley, E.; O'Farrell, P. H. Nitric oxide contributes to induction of innate immune responses to gram-negative bacteria in Drosophila Genes Dev. 2003, 17, 115-125
13. MacMicking, J.; Xie, Q. W.; Nathan, C. Nitric oxide and macrophage function Annu. Rev. Immunol. 1997, 15, 323-350
14. Mannick, J. B. Immunoregulatory and antimicrobial effects of nitrogen oxides Proc. Am. Thorac. Soc. 2006, 3, 161-165
15. Wink, D. A.; Mitchell, J. B. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radical Biol. Med. 1998, 25 (4) 434-456
16. Moller, M. N.; Li, Q.; Lancaster, J. R. J.; Denicola, A. Acceleration of nitric oxide autooxidation and nitrosation by membranes Life 2007, 59, 243-248
17. Zaki, M. H.; Akuta, T.; Akaike, T. Nitric oxide-induced nitrative stress involved in microbial pathogenesis J. Pharmacol. Sci. 2005, 98, 117-129
18. Wink, D. A.; Kasprzak, K. S.; Maragos, C. M.; Elespuru, R. K.; Misra, M.; Dunams, T. M.; Cebula, T. A.; Koch, W. H.; Andrews, A. W.; Allen, J. S.; Keefer, L. K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors Science 1991, 254, 1001-1003
19. Schapiro, J. M.; Libby, S. J.; Fang, F. C. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 8496-8501
20. Ghaffari, A.; Miller, C. C.; McMullin, B.; Ghahary, A. Potential application of gaseous nitric oxide as a topical antimicrobial agent Nitric Oxide 2006, 14, 21-29
21. Raulli, R.; McElhaney-Feser, G.; Hrabie, J. A.; Cihlar, R. L. Antimicrobial properties of nitric oxide using diazeniumdiolates as the nitric oxide donor Recent Res. Dev. Microbiol. 2002, 6, 177-183
22. Keefer, L. K. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates Annu. Rev. Pharmacol. Toxicol. 2003, 43, 585-607
23. Hetrick, E. M.; Schoenfisch, M. H. Antibacterial nitric oxide-releasing xerogels: Cell viability and parallel plate flow cell adhesion studies Biomaterials 2007, 28, 1948-1956
24. Hetrick, E. M.; Shin, J. H.; Stasko, N. A.; Johnson, B. A.; Wespe, D. A.; Holmuhamedov, E.; Schoenfisch, M. H. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles ACS Nano 2007, 2, 235-246
25. Nablo, B. J.; Rothrock, A. R.; Schoenfisch, M. H. Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants Biomaterials 2005, 26, 917-924
26. Levy, S. B. The Antibiotic Paradox, 2nd ed.; Perseus: Cambridge, 2002.
27. Kliebe, C.; Nies, B. A.; Meyer, J. F.; Tolxdorff-Neutzling, R. M.; Wiedemann, B. Evolution of plasmid-encoded resistance to broad-spectrum cephalosporins Antimicrob. Agents Chemother. 1985, 28, 302-307
28. Hall, R. M.; Collins, C. M. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination Mol. Microbiol. 1995, 15, 593-600
29. Levy, S. B. Multidrug resistance: a sign of the times N. Engl. J. Med. 1998, 338, 1376-1378
30. Hiramatsu, K. Vancomycin resistance in Staphylococci Drug Resist. Updates 1998, 1, 135-150
31. Michel, M.; Gutmann, L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities Lancet 1997, 349, 1901-1906
32. Cottarel, G.; Wierzbowski, J. Combination drugs, an emerging option for antibacterial therapy Trends Biotechnol. 2007, 25, 547-555
33. Eliopoulos, G. M.; Moellering, R. C., Jr. Antimicrobial Combinations. In Antibiotics in Laboratory Medicine, 4th ed.; Lorian, V., Eds.; Williams & Wilkins: Baltimore, 1996; pp 330 - 396.
34. Eliopoulos, G. M.; Eliopoulos, C. T. Antibiotic combinations: Should they be tested Clin. Microbiol. Rev. 1988, 1 (2) 139-156
35. Saavedra, J. E.; Southan, G. J.; Davies, K. M.; Lundell, A.; Markou, C.; Hanson, S. R.; Adrie, C.; Hurford, W. E.; Zapol, W. M.; Keefer, L. K. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor J. Med. Chem. 1996, 39, 4361-4365
36. Amsterdam, D. Susceptibility Testing of Antimicrobials in Liquid Media. In Antibiotics in Laboratory Medicine, 4th ed.; Lorian, V., Eds.; Williams & Wilkins: Baltimore, 1996; pp 52 - 111.
37. Elion, G. B.; Singer, S.; Hitchings, C. H. Antagonists of nucleic acid derivitives. VIII. Synergism in combinations of biochemically related antimetabolites J. Biol. Chem. 1954, 208, 477-488
38. Rosenkranz, H. S.; Carr, H. S. Silver sulfadiazine: Effect on the growth and metabolism of bacteria Antimicrob. Agents Chemother. 1972, 2, 367-372
39. Kwakman, P. H. S.; Van den Akker, J. P. C.; Güçlü, A.; Aslami, H.; Binnekade, J. M.; de Boer, L.; Boszhard, L.; Paulus, F.; Middelhoek, P.; te Velde, A. A.; Vandenbroucke-Grauls, C. M. J. E.; Schultz, M. J. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization Clin. Infect. Dis. 2008, 46, 1677-1682
40. Akimitsu, N.; Hamamoto, H.; Inoue, R.; Shoji, M.; Akamine, A.; Takemori, K.; Hamasaki, N.; Sekimizu, K. Increase in resistance of methicillin-resistant Staphylococcus aureus to β-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals Antimicrob. Agents Chemother. 1999, 43, 3042-3043
41. Datta, N.; Faiers, M. C.; Reeves, D. S.; Brumfitt, W.; Orskov, F.; Orskov, I. R factors in Escherichia coli in faeces after oral chemotherapy in general practice Lancet 1971, 1, 312-315
42. Levy, S. B.; Marshall, B.; Schluederberg, S.; Rowse, D.; Davis, J. High frequency of antimicrobial resistance in human fecal flora Antimicrob. Agents Chemother. 1988, 32, 1801-1806
43. Rosenkranz, H. S.; Coward, J. E.; Wlodkowski, T. J.; Carr, H. S. Properties of silver sulfadiazine-resistant Enterobacter cloacae Antimicrob. Agents Chemother. 1973, 5, 199-201
44. De Groote, M. A.; Fang, F. C. NO inhibitions: antimicrobial properties of nitric oxide Clin. Infect. Dis. 1995, 21 (Suppl. 2) S162-S165
45. Deupree, S. M.; Schoenfisch, M. H. Morphological analysis of the antimicrobial action of nitric oxide on Gram-negative pathogens using atomic force microscopy Acta Biomater. 2009, 5 (5) 1405-1415
46. Liau, S. Y.; Read, D. C.; Pugh, W. J.; Furr, J. R.; Russell, A. D. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions Lett. Appl. Microbiol. 1997, 25, 279-283
47. Zarfl, C.; Matthies, M.; Klasmeier, J. A mechanistical model for the uptake of sulfonamides by bacteria Chemosphere 2008, 70, 753-760
48. Sakurai, H.; Ishimitsu, T. Microionization constants of sulphonamides Talanta 1980, 27, 293-298
49. Klasen, H. J. Historical review of the use of silver in the treatment of burns. I. Early uses Burns 2000, 26, 117-130
50. Nikaido, H.; Vaara, M. Molecular basis of bacterial outer membrane permeability Microbiol. Rev. 1985, 49, 1-32
51. Maillard, J.-Y. Bacterial target sites for biocide action J. Appl. Microbiol. 2002, 92 (s1) 16S-27S
52. Coward, J. E.; Carr, H. S.; Rosenkranz, H. S. Silver sulfadiazine: Effect on the ultrastructure of Pseudomonas aeruginosa Antimicrob. Agents Chemother. 1973, 3, 621-624
53. Moellering, J., R. C.; Weinberg, A. N. Studies on antibiotic synergism against enterococci. II. Effect of various antibiotics on the uptake of 14C-labeled streptomycin by enterococci J. Clin. Invest. 1971, 50, 2580-2584
54. Moellering, J., R. C.; Wennersten, C.; Weinberg, A. N. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies J. Lab. Clin. Med. 1971, 77, 821-828
55. Chilton, P.; Isaacs, N. S.; Manas, P.; Mackey, B. M. Biosynthetic requirements for the repair of membrane damage in pressure-treated Escherichia coli Int. J. Food Microbiol. 2001, 71 (1) 101-104